Zymeworks Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
ZYME Nasdaq 2836 www.zymeworks.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Zymeworks Inc.

Zymeworks Announces Leadership Appointments and Transitions to Align with Evolution of Corporate Strategy - Jan 12th, 2026 4:00 am
Zymeworks Outlines Strategic Priorities and Outlook for 2026 - Jan 11th, 2026 4:00 pm
Ziihera® (zanidatamab-hrii) Combinations Achieve Unprecedented Results in First-Line HER2+ Locally Advanced or Metastatic GEA including more than Two Years Median Overall Survival Benefit - Jan 6th, 2026 11:34 am
3 Stocks Estimated To Trade At Discounts Of Up To 49.7% - Dec 19th, 2025 4:38 am
Is Zymeworks Inc. (NASDAQ:ZYME) Trading At A 50% Discount? - Dec 19th, 2025 3:55 am
Oracle initiated, Uber upgraded: Wall Street's top analyst calls - Dec 3rd, 2025 7:35 am
Zymeworks Announces Participation in Upcoming Conferences - Dec 2nd, 2025 2:05 pm
Zymeworks Announces Participation in Upcoming Investor Conferences - Nov 24th, 2025 4:00 am
Zymeworks (ZYME): Assessing Valuation After 60% Rally and Recent Earnings Momentum - Nov 19th, 2025 7:14 am
JAZZ Hits 52-Week High on Encouraging Gastric Cancer Study Data - Nov 18th, 2025 10:16 am
Zymeworks to change course, pursue ‘royalty-driven’ biotech model - Nov 18th, 2025 1:38 am
Zymeworks Appoints Scott Platshon as Acting Chief Investment Officer - Nov 17th, 2025 11:01 pm
Zymeworks Announces Strategic Initiative to Optimize Value of Licensed Products by Building a Diversified Portfolio of Revenue-Generating Assets - Nov 17th, 2025 11:00 pm
Jazz, Zymeworks Catapult On Their 'Sweeping Success' In Gastric Cancer - Nov 17th, 2025 2:44 pm
Stocks to Watch Recap: Alphabet, Tesla, Netflix, Zymeworks - Nov 17th, 2025 2:13 pm
Jazz Pharmaceuticals and Zymeworks Report Positive Cancer Treatment Results. The Stocks Soar. - Nov 17th, 2025 9:08 am
Traders Eye Delayed Jobs Report, Nvidia Earnings, Stifling US Equity Futures Pre-Bell - Nov 17th, 2025 6:59 am
Zymeworks Announces Positive HERIZON-GEA-01 Phase 3 Results Supporting Ziihera® (zanidatamab-hrii) as HER2-Targeted Agent-of-Choice and New Standard of Care in First-Line HER2-Positive Locally Advanced or Metastatic Gastroesophageal Adenocarcinoma - Nov 17th, 2025 4:00 am
Zymeworks Inc. (NASDAQ:ZYME) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock? - Nov 9th, 2025 6:22 am
Zymeworks Inc. (ZYME) Reports Q3 Loss, Lags Revenue Estimates - Nov 6th, 2025 3:35 pm